Health News & Analysis
50 articles
Market Mood
Medical Aid in Dying Laws Change for Terminally Ill Patients
New laws are making it easier for terminally ill individuals to access Medical Aid in Dying. To qualify, patients must meet three specific conditions. This change could potentially impact how end-of-life decisions are made in the healthcare field. Understanding these regulations is crucial for patients and families facing terminal illness.
Read More: Medical Aid in Dying Laws Change for Terminally Ill Patients
NFL Biosciences Submits Phase 2 Smoking Cessation Trial
NFL Biosciences has submitted its Phase 2 smoking cessation trial to regulators. This clinical trial is a significant step in the development of potential treatments aimed at helping individuals quit smoking. The success of such trials can lead to market opportunities in the healthcare sector. For investors, advancements in clinical trials can indicate future revenue potential for companies involved in healthcare innovations like NFL Biosciences.
Read More: NFL Biosciences Submits Phase 2 Smoking Cessation Trial
Medicare Splits $2,100 Drug Bill Into Monthly Payments
Medicare's annual drug cap for 2026 is set at $2,100, up from $2,000 in 2025. Beneficiaries can split this cost into monthly payments of roughly $175 but must opt in through their Part D plan. Enrolling after September reduces the benefit, as there would be fewer months to spread the payments. This option allows individuals to manage their financial exposure better, particularly in light of a 2.8% increase in Social Security checks for 2026. Understanding these details can help retirees avoid financial strain when managing healthcare costs.
Read More: Medicare Splits $2,100 Drug Bill Into Monthly Payments
FDA Panel Eases Access to Popular Peptides for Consumers
The FDA panel has voted to support easier access to peptides, specifically placing the peptide BPC-157 on the compounding list, which allows pharmacies to create custom medications. This move aims to address the growing interest in these products, particularly online and among wellness influencers. The decision may influence market behavior as companies involved in peptide production could see increased demand. This is significant for investors as it could lead to new business opportunities in the health and wellness sector.
Read More: FDA Panel Eases Access to Popular Peptides for Consumers
Nolan Wells Autopsy Results Show Undetermined Cause of Death
An independent autopsy conducted on Nolan Wells has found the cause of death to be 'undetermined.' This conclusion is based on the examination of his body following his passing. The findings could invoke further investigation into the circumstances surrounding his death. Determining the cause of death is crucial for legal and medical assessments, and can impact public health inquiries. This matter continues to be significant for those concerned with safety and regulatory concerns.
Read More: Nolan Wells Autopsy Results Show Undetermined Cause of Death
Congo Ebola Outbreak: 930 Confirmed Deaths Reported
A reported 930 people have died due to the ongoing Ebola outbreak in Congo. This outbreak poses serious health risks and challenges for the affected region. The rising number of fatalities could impact local governance and healthcare resources. It is crucial for investors to monitor how public health crises can influence market stability and operational risks in the region.
Read More: Congo Ebola Outbreak: 930 Confirmed Deaths Reported
Wildfire Smoke Pollution Hits Chicago, NYC, Detroit Today
On Thursday, Chicago, Detroit, Minneapolis, and New York City ranked among the world's most polluted cities due to wildfire smoke. This pollution is linked to increasing cardiovascular threats, impacting residents' health. The article highlights the urgency of addressing air quality issues in these urban areas. For ordinary investors, awareness of environmental health trends may influence sectors such as healthcare and urban development.
Read More: Wildfire Smoke Pollution Hits Chicago, NYC, Detroit Today
Hegseth Announces Testosterone Screening for US Troops
Hegseth has announced the implementation of testosterone screening for U.S. troops. This initiative addresses issues related to hormone health among military personnel. The screening aims to diagnose and treat testosterone deficiency, which can impact physical performance and overall well-being. This proactive measure may lead to improved health outcomes for service members, thereby affecting military readiness and performance. Such health initiatives are significant as they can influence recruitment and retention in the military sector.
Read More: Hegseth Announces Testosterone Screening for US Troops
US Quarantine Order for Americans May Hinder Ebola Response
An aid group has stated that the US quarantine order for Americans returning from Congo could negatively impact the Ebola response efforts. This order may lead to a decrease in support and resources needed for managing the Ebola outbreak. The exact timeline for the implementation of the order is not specified, highlighting uncertainty in the aid community. This situation could increase challenges for public health officials as they work to control the outbreak in affected areas.
Read More: US Quarantine Order for Americans May Hinder Ebola Response
Ebola Cases Rise in Eastern Congo Amid Unknown Transmission Chains
A significant number of new Ebola cases in eastern Congo are attributed to unknown transmission chains. The outbreak worsens, outpacing current response efforts. Specific figures on the total number of cases or deaths were not provided. This situation raises concerns about public health and safety, affecting local communities and resource allocation. For investors, the ongoing public health crisis may lead to increased market volatility, particularly in sectors related to health and safety.
Read More: Ebola Cases Rise in Eastern Congo Amid Unknown Transmission Chains
Cyclospora Outbreak Surges Past 1,000 Cases in Michigan
Nearly 1,000 cases of cyclospora infection have been reported in Michigan, marking the largest outbreak in the state's history. As of Wednesday, 992 individuals have been diagnosed, with around 40 hospitalizations noted. The outbreak began with over 170 cases since June 22, 2023, and is linked to similar illnesses in 28 other states, notably Ohio, which reported 306 cases. Investigations into the outbreak are ongoing, highlighting the challenges in tracing foodborne illnesses. This situation is significant for public health and local economies as it can impact food consumption and safety perceptions.
Read More: Cyclospora Outbreak Surges Past 1,000 Cases in Michigan
Graham's Death Linked to Aortic Tear, Preliminary Findings Released
Preliminary findings indicate Graham died from an aortic tear. This condition is critical as it can lead to life-threatening complications if not addressed promptly. The news may impact investor sentiment towards health-related stocks or insurance companies involved in critical care. Understanding such medical conditions can influence investment in healthcare sectors, especially for companies dealing with emergency medical procedures.
Read More: Graham's Death Linked to Aortic Tear, Preliminary Findings Released
US CDC Reports Ebola Virus Case in Congo Involving US Citizen
The US Centers for Disease Control and Prevention (CDC) confirmed that a US citizen has tested positive for the Ebola virus in the Democratic Republic of Congo. The case highlights ongoing public health concerns related to Ebola outbreaks in the region. According to the CDC, the affected individual had traveled to areas affected by the virus. This situation impacts health services and may affect travel and trade considerations for investors interested in sectors related to health and travel safety.
Read More: US CDC Reports Ebola Virus Case in Congo Involving US Citizen
Lilly (LLY) to Present Alzheimer's Research at London Conference
Eli Lilly (LLY) announced it will present new research on Alzheimer's at a conference in London. This presentation is part of their ongoing efforts to advance treatments for Alzheimer's disease. Lilly's research could influence market perceptions significantly, especially regarding healthcare investments. The results from such studies are important for investors monitoring the pharmaceutical sector.
Read More: Lilly (LLY) to Present Alzheimer's Research at London Conference
TransMedics Group (TMDX) Expands Organ Transport Solutions
TransMedics Group (TMDX) focuses on improving organ transplant logistics. The company has developed the Organ Care System (OCS) that maintains donor organs in a viable state during transport. Currently, there are over 90,000 people in the U.S. waiting for kidney transplants, and TMDX is working to expand its OCS to kidneys. Additionally, TransMedics is investing in the European market through a partnership with PAD Aviation and ground transportation collaborations in Italy. These efforts could significantly increase their addressable market.
Read More: TransMedics Group (TMDX) Expands Organ Transport Solutions
Ebola Treatment Trial Starts in DRC, WHO Announces
The World Health Organization (WHO) has reported that a trial for Bundibugyo Ebola treatment has commenced in the Democratic Republic of Congo (DRC). This trial aims to address the resurgence of the virus in the region. The significance of this trial is heightened by previous outbreaks and their impact on public health. Continued monitoring and research are crucial in understanding the disease's spread and potential containment measures.
Read More: Ebola Treatment Trial Starts in DRC, WHO Announces
Biohub's Rare As One Network Opens $150M Funding Round
Biohub, funded by Chan Zuckerberg Initiative, announced it will open a new funding round for its Rare As One Network this fall. This will be the fourth round, with over $150 million committed to rare disease initiatives in total. The focus will be on rare pulmonary and immune diseases, as well as rare cancers. Additionally, Biohub is expanding its partnership with Every Cure to leverage AI for drug repurposing, aiming to enhance patient-centric research programs.
Read More: Biohub's Rare As One Network Opens $150M Funding Round
Moderna (MRNA) Receives Unanimous FDA Panel Approval for mRNA Vaccine
The FDA advisory panel voted unanimously to approve Moderna's (MRNA) mRNA flu vaccine for older adults. This decision may impact the market by potentially increasing demand for Moderna's vaccine offerings. The mRNA flu vaccine is expected to enhance B cell response breadth in humans, a factor that could improve public health outcomes. The approval comes after prior controversies surrounding the vaccine's deployment, adding weight to the FDA's endorsement.
Read More: Moderna (MRNA) Receives Unanimous FDA Panel Approval for mRNA Vaccine
GLP-1 Drugs: New Weight-Loss Therapies Under Development
New experimental weight-loss therapies are being developed to potentially outperform existing GLP-1 medications, such as Zepbound and Wegovy. Specific data points and timelines for these therapies are not provided in the article. The advancement in this sector could impact the market by affecting the sales and adoption of current GLP-1 products. Stakeholders in companies involved in diabetes and obesity treatments should monitor the progress of these new drug candidates.
Read More: GLP-1 Drugs: New Weight-Loss Therapies Under Development
Blood Test Aids Colon Cancer Screening Amid 50M Unscreened Americans
A new blood test has been developed to assist in the detection of colon cancer. Currently, about 50 million Americans are not undergoing screening for colon cancer, coinciding with rising rates of the disease. This test may provide an alternative option for those hesitant to undergo conventional screening. The implications of this development could influence healthcare markets and patient access to cancer screenings.
Read More: Blood Test Aids Colon Cancer Screening Amid 50M Unscreened Americans
Congo Ebola Cases Rise Amid Attack on Burial Team
Congo's health authorities reported an increase in Ebola cases in the region. The situation is worsened by an attack on a burial team tasked with handling deceased Ebola patients, which poses risks for the containment of the outbreak. The rising cases could impact public health responses and international engagements in Congo. Monitoring and intervention efforts are critical to prevent further spread of the virus.
Read More: Congo Ebola Cases Rise Amid Attack on Burial Team
DRC Ebola Cases Reach 344, WHO Response Update
The World Health Organization (WHO) reported that confirmed Ebola cases in the Democratic Republic of the Congo (DRC) have reached 344. The rising number is critical as it indicates an ongoing health crisis that could impact local and global markets. The WHO's efforts to respond to the outbreak are intensifying, with resources being allocated to manage the situation effectively. Tracking such health events is important because they can affect market conditions, particularly in related sectors such as pharmaceuticals and public health.
Read More: DRC Ebola Cases Reach 344, WHO Response Update
WHO Chief Calls for Funding in Congo Ebola Response Efforts
The World Health Organization (WHO) has initiated a rallying call for increased funding to enhance the response to the Ebola outbreak in Congo. The WHO's efforts highlight the necessity for enhanced resource allocation to address public health crises effectively. This emphasis on funding is crucial as outbreaks can impact local economies and global markets. Without sufficient financial support, the response to such health emergencies may be hindered, leading to broader implications for health security and market stability.
Read More: WHO Chief Calls for Funding in Congo Ebola Response Efforts
Replimune (REPL) Drug Receives New Chance After White House Action
Replimune (REPL) received governmental intervention regarding its drug, which earlier faced significant hurdles. The White House's role in facilitating another opportunity for the therapy highlights the importance of federal support in the biotech sector. The specific effects of this intervention on stock prices or market performance were not disclosed, but such actions can influence investor sentiment. The approval status and market reactions will be essential to monitor moving forward.
Read More: Replimune (REPL) Drug Receives New Chance After White House Action
Cancer Treatment Costs Could Rise Significantly in Future Outlook
Cancer treatment costs are currently reaching hundreds of thousands of dollars. With potential increases in costs anticipated, the financial burden on patients may grow. The implications of such rising costs could impact healthcare markets and patient access to necessary treatments. Official statements regarding specific cost projections were not provided in the article.
Read More: Cancer Treatment Costs Could Rise Significantly in Future Outlook
Ebola Cases Surge in Congo Amid Shortage of Medical Tools
Congo is experiencing a surge in Ebola cases, with reports indicating rising infection numbers. The lack of essential medical tools is concerning for public health and could exacerbate the situation. As the outbreak grows, the demand for medical supplies is critical to manage the crisis. This development may have implications for global health markets and aid resources as efforts intensify to control the spread of the virus.
Read More: Ebola Cases Surge in Congo Amid Shortage of Medical Tools
Moderna (MRNA) to Review Flu Vaccine at FDA Expert Committee Meeting
The US FDA announced it will hold a meeting with an expert committee to review the flu vaccine developed by Moderna (MRNA). This meeting is crucial as it will assess the vaccine's efficacy and safety. Given the increasing interest in flu vaccinations, particularly in the context of ongoing health concerns, this evaluation may impact market perception of Moderna's future revenues. The outcome of the review could influence both Moderna's stock performance and broader market trends in the biotech sector.
Read More: Moderna (MRNA) to Review Flu Vaccine at FDA Expert Committee Meeting
CDC Vaccine Panel Changes Reviewed by US Health Sec. Kennedy
US Health Secretary Kennedy has announced a review of recent changes to the CDC's vaccine panel. The review comes amid concerns regarding the panel's efficacy and recommendations. While specific data was not provided, this move may impact ongoing public health strategies and funding for vaccine programs, emphasizing the importance of vaccination in managing health crises. This situation could influence market sentiment, particularly concerning health sectors and related investments.
Read More: CDC Vaccine Panel Changes Reviewed by US Health Sec. Kennedy
U.S. Bans Entry for Non-Passport Holders Amid Ebola Cases
A U.S. physician tested positive for Ebola and will be moved, along with six other Americans in Congo, to Germany. In response to the situation, the U.S. government has implemented a ban on entry for individuals without U.S. passports who have recently been in Congo, Uganda, or South Sudan. This move is significant as it aims to prevent further Ebola transmission and protect public health. The response highlights the ongoing efforts to manage infectious diseases and their potential implications for travel and markets.
Read More: U.S. Bans Entry for Non-Passport Holders Amid Ebola Cases
Ebola outbreak causes 80 deaths in Congo and Uganda, WHO responds
The World Health Organization (WHO) has declared a public health emergency due to a rare strain of the Ebola virus, which has resulted in 80 deaths across Congo and Uganda. This declaration highlights the potential risks posed by the outbreak and aims to mobilize international support and resources to contain its spread. The situation is crucial as it may impact healthcare systems and potentially affect market sentiment towards related sectors. Effective management of this outbreak is important to mitigate broader health and economic implications.
Read More: Ebola outbreak causes 80 deaths in Congo and Uganda, WHO responds
WHO Announces Global Emergency Over Untreatable Ebola Strain
The World Health Organization (WHO) has declared a global emergency concerning a rare, untreatable strain of Ebola. This has raised concerns among health officials and could lead to increased surveillance and readiness in various countries. The implications for global markets are significant, as any outbreak could affect travel, trade, and healthcare costs. As of now, there are no confirmed cases reported outside endemic regions, but the alert highlights potential risks that could influence market stability.
Read More: WHO Announces Global Emergency Over Untreatable Ebola Strain
WHO Declares Ebola (Global Health Emergency) in Congo, Uganda
The WHO has declared the Ebola outbreak in Congo and Uganda a global health emergency. This designation could prompt increased international response and funding to combat the virus. The outbreak has raised concerns about the potential for spread beyond the region, leading to heightened vigilance in health protocols. Managing the situation effectively is critical for public health and could influence global market dynamics in health-related sectors.
Read More: WHO Declares Ebola (Global Health Emergency) in Congo, Uganda
CDC Reports No Current Hantavirus Cases, 41 Monitored Individuals
As of Thursday, the CDC confirmed that there are no hantavirus cases in the U.S., while monitoring 41 individuals. This comes after a cruise ship outbreak that has led to 11 total cases worldwide, with eight confirmed by lab tests and three fatalities. The public health risk remains low, and individuals being monitored have been advised to stay home for 42 days. Despite concerns about potential global health implications, experts indicate a limited risk of widespread transmission due to the unique characteristics of the Andes strain.
Read More: CDC Reports No Current Hantavirus Cases, 41 Monitored Individuals
CDC Reports No Hantavirus Cases in US: 41 Under Monitoring
The CDC has announced that there are currently no reported cases of hantavirus in the United States. However, 41 individuals are being monitored due to potential exposure. This development plays a critical role in public health communications and resource allocation. Monitoring can help prevent the spread of infectious diseases and reassure the public regarding safety. Such announcements may impact market sectors related to healthcare and public safety.
Read More: CDC Reports No Hantavirus Cases in US: 41 Under Monitoring
Fangzhou and Tenry Pharmaceuticals Partner on Diabetes Care Initiative
Fangzhou has entered into a partnership with Tenry Pharmaceutical to enhance diabetes care solutions. This collaboration aims to leverage both companies' strengths in healthcare to improve patient outcomes. The specifics of the partnership, including financial details or forecasted impacts on market shares, were not disclosed. The collaboration can potentially influence market trends in the healthcare sector as diabetes prevalence continues to rise, highlighting the significance of innovative care solutions.
Read More: Fangzhou and Tenry Pharmaceuticals Partner on Diabetes Care Initiative
CDC Reports Low Hantavirus Risk in US Public
The CDC stated that the risk of Hantavirus to the US public is low. This is significant as it informs public health policy and individual precautions. The statement provides clarity amidst concerns regarding viral outbreaks. Monitoring and surveillance continue as part of health safety protocols, but no immediate threats have been identified.
Read More: CDC Reports Low Hantavirus Risk in US Public
CDC Response to Hantavirus Affects Public Health Strategy
The CDC is addressing the hantavirus situation, balancing health responses without specific numerical data. The agency's actions impact public health measures and safety protocols. Although the response is under scrutiny, no concrete figures, changes, or statements indicating direct market impact were provided. This situation emphasizes the significance of public health management in economic contexts.
Read More: CDC Response to Hantavirus Affects Public Health Strategy
FDA Leadership Change Amid Hantavirus Concerns in US
Kyle Diamantas was appointed as the acting leader of the FDA amidst rising concerns over a hantavirus outbreak. The appointment is critical as the FDA faces ongoing vacancies that may affect its responsiveness to health crises. The leadership transition could influence regulatory decisions and public health initiatives. This development underscores the importance of having stable leadership in health agencies during emerging health threats.
Read More: FDA Leadership Change Amid Hantavirus Concerns in US
Health Officials Board Ship for Hantavirus Evacuation Spanning Multiple Nations
Spanish health officials have boarded a ship affected by hantavirus to evacuate passengers. This operation may involve cooperation from international health agencies and could impact public health responses. No specific numbers or figures regarding the passengers or the number of health officials involved were provided. The situation highlights the importance of addressing health threats quickly, but no concrete market implications are mentioned.
Read More: Health Officials Board Ship for Hantavirus Evacuation Spanning Multiple Nations
Hantavirus Update: Cruise Ship Evacuation in Tenerife
A cruise ship carrying passengers with possible hantavirus symptoms has arrived in Tenerife. Health officials have indicated that those exhibiting symptoms may need to be isolated on the island. This situation raises health concerns that could impact travel and tourism in the region. The evacuation process is part of efforts to manage potential health risks associated with the virus.
Read More: Hantavirus Update: Cruise Ship Evacuation in Tenerife
EU Health Agency Classifies Hantavirus Contacts as High-Risk
According to an EU health agency statement, all passengers on a ship affected by hantavirus are now considered high-risk contacts. This classification is critical as it potentially affects public health responses and resource allocation for monitoring and treatment. The agency's assessment underscores the seriousness of health threats posed by hantavirus, with implications for maritime and passenger health regulations. Monitoring will be essential to prevent further spread and ensure safety for affected individuals.
Read More: EU Health Agency Classifies Hantavirus Contacts as High-Risk
Evacuations Planned for Hantavirus-Hit Cruise Ship
European countries are preparing to send planes to evacuate citizens from a cruise ship affected by hantavirus. This development follows health concerns regarding the virus, which can spread through rodent droppings and urine. The exact number of citizens being evacuated and the specific countries involved have not yet been disclosed. The situation underscores ongoing public health challenges and may impact travel and tourism sectors in affected regions.
Read More: Evacuations Planned for Hantavirus-Hit Cruise Ship
Trump Expected to Fire FDA Head Amid Agency Turbulence
Marty Makary is reported to be the latest high-profile health official facing termination, as political dynamics shift within the Trump administration. His departure continues a trend of leadership changes affecting key health agencies. This could impact the Food and Drug Administration (FDA) as it navigates ongoing public health challenges. Market reactions to such changes in leadership at the FDA can lead to volatility in healthcare stocks.
Read More: Trump Expected to Fire FDA Head Amid Agency Turbulence
Trump Poised to Remove FDA Commissioner, Impacts on Health Sector
Former President Donald Trump is reportedly considering the dismissal of the FDA Commissioner. This potential change could influence regulatory dynamics within the healthcare sector, impacting pharmaceutical and biotech companies reliant on FDA approvals. Without concrete official announcements or specific timelines, the exact market repercussions remain uncertain. The health sector may experience volatility should the dismissal occur, affecting companies with ties to the FDA's regulatory processes.
Read More: Trump Poised to Remove FDA Commissioner, Impacts on Health Sector
Hantavirus Not a Pandemic, Experts Confirm
According to infectious disease experts, hantavirus is not expected to cause a pandemic, labeling it a 'one-off situation.' The statement indicates that the risk of contracting hantavirus is highly situational, dependent on specific environmental conditions. This assessment may have implications for public health responses and resource allocation, but no concrete statistical data or trends were mentioned in the article. Therefore, while the news may calm public concerns, there are no actionable market insights related to the impact on any specific companies.
Read More: Hantavirus Not a Pandemic, Experts Confirm
Amazon (AMZN) Offers Ozempic Pill with Same-Day Delivery
Amazon.com (AMZN) has announced that its pharmacy will stock Novo Nordisk's Ozempic pill for type 2 diabetes, offering same-day delivery in approximately 3,000 locations, expanding to 4,500 by year-end. Patients can order the medication for $149 per month or $25 with insurance. Amazon has been providing GLP-1 medications since 2021 and previously stocked Novo's Wegovy weight-loss drug. The initiative aims to enhance access to medications for customers, with half of U.S. customers eligible for same-day delivery.
Read More: Amazon (AMZN) Offers Ozempic Pill with Same-Day Delivery
Hantavirus Andes Strain Cases Confirmed from MV Hondius Cruise
In late April, at least two individuals left the MV Hondius cruise ship, with one later testing positive for the Andes strain of hantavirus. This outbreak highlights concerns regarding public health related to rare infections. As hantavirus outbreaks are infrequent, officials will likely monitor the situation closely to prevent spread. The implications for the cruise industry could be significant should further cases arise, potentially affecting consumer confidence.
Read More: Hantavirus Andes Strain Cases Confirmed from MV Hondius Cruise
Brazil Approves BridgeBio (BRID) Acoramidis Treatment for Heart Condition
Brazil's health regulatory agency has approved BridgeBio Pharma's (BRID) acoramidis for the treatment of transthyretin amyloid cardiomyopathy, a serious heart condition. This approval is significant as it provides new treatment options for patients suffering from this condition. The company's stock may react positively to this development as it expands its product offerings in the cardiology space. The approval follows a series of clinical trials demonstrating the drug's efficacy, aligning with BridgeBio's growth strategy in the biopharmaceutical market.
Read More: Brazil Approves BridgeBio (BRID) Acoramidis Treatment for Heart Condition
Hantavirus Outbreak Raises Concerns Over Public Health Situation
A rare form of hantavirus, specifically the Andes virus, has raised concerns about a potential outbreak spread from person to person. This situation could have significant implications for public health and safety protocols. Health authorities are monitoring the situation closely, but specific numbers or data points regarding affected individuals or incidence rates were not reported. The outbreak's impact on the cruise industry and related markets remains uncertain without concrete metrics or statements from relevant organizations.
Read More: Hantavirus Outbreak Raises Concerns Over Public Health Situation
UnitedHealthcare (UNH) Network Changes Impact Medicare Advantage Plans
Millions of Americans are losing Medicare Advantage plans due to network changes, with significant discontent among hospitals and physicians regarding insurance restrictions. A notable incident saw UnitedHealthcare (UNH) end its contract with Johns Hopkins Medicine in August, removing most Johns Hopkins facilities from coverage. This leads to increased out-of-pocket costs for patients if they seek care from out-of-network providers. The abandonment of a proposed CMS rule aimed at simplifying midyear enrollment changes further complicates the situation for affected enrollees.
Read More: UnitedHealthcare (UNH) Network Changes Impact Medicare Advantage Plans